"Les Hôpitaux Universitaires de Marseille AP-HM représentent le 3e Centre Hospitalier Universitaire de France. Ses missions sont le soin, la formation, la recherche ainsi que la prévention et l'éducation à la santé. Ses établissements offrent toute la gamme des spécialités, du soin de proximité aux traitements de pointe de pathologies complexes et rares, pour adultes et enfants. Ses équipes médicales et soignantes sont engagées dans une dynamique de soins d'excellence et de proximité, accessibles à tous."

During the past decade, Assistance Publique Hôpitaux de Marseille conducted 367 clinical trials. In the 10-year time frame, 367 clinical trials started and 1 clinical trials were completed, i.e. on average, 0.3% percent of trials that started reached the finish line to date. In the past 5 years, 95 clinical trials started and 1 clinical trials were completed. i.e. 1.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Assistance Publique Hôpitaux de Marseille" #1 sponsor was "Assistance Publique Hopitaux De Marseille" with 447 trials, followed by "Nantes University Hospital" with 14 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 13 trials sponsored, "University Hospital, Bordeaux" with 13 trials sponsored and "Centre Hospitalier Universitaire de Nice" with 13 trials sponsored. Other sponsors include 107 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Assistance Publique Hôpitaux de Marseille" #1 collaborator was "Ministry of Health, France" with 9 trials as a collaborator, "Assistance Publique Hopitaux De Marseille" with 6 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Hospices Civils de Lyon" with 3 trials as a collaborator and "Innate Pharma" with 3 trials as a collaborator. Other collaborators include 120 different institutions and companies that were collaborators in the rest 115 trials.

According to Clinical.Site data, the most researched conditions in "Assistance Publique Hôpitaux de Marseille" are "Cancer" (9 trials), "Multiple Sclerosis" (8 trials), "Acute Coronary Syndrome" (7 trials), "Epilepsy" (5 trials) and "Leukemia" (5 trials). Many other conditions were trialed in "Assistance Publique Hôpitaux de Marseille" in a lesser frequency.

Most popular intervention types in "Assistance Publique Hôpitaux de Marseille" are "Other" (242 trials), "Drug" (119 trials), "Device" (84 trials), "Biological" (70 trials) and "Procedure" (67 trials). Other intervention types were less common.

The name of intervention was led by "blood samples" (23 trials), "blood sample" (17 trials), "Placebo" (15 trials), "Blood sample" (13 trials) and "MRI" (13 trials). Other intervention names were less common.

The vast majority of trials in "Assistance Publique Hôpitaux de Marseille" are 567 trials for "All" genders, 35 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Assistance Publique Hôpitaux de Marseille". 13 are not yet recruiting, 78 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 228 completed trials in Assistance Publique Hôpitaux de Marseille, 1 suspended trials, and 26 terminated clinical trials to date.

Out of the total trials that were conducted in Assistance Publique Hôpitaux de Marseille, 11 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 360 trials that are defined as “Not Applicable".

Assistance Publique Hôpitaux de Marseille has several departments that took part in Clinical trials: "Servie de Pneumologie et centre de Transplantation Pulmonaire" - 2 trials